Search research articles
Contact Us
Filters
Showing results (21-30 of 39) with videos related to
Page
of 4
Sort By:
World Journal of Surgery
|
November 4, 2024
Safety of thyroidectomy as day care surgery at a rural setting in Eastern Uganda
Joseph Okello Damoi, Marnie Abeshouse, Angellica Giibwa, et al.
American Journal of Hematology
|
August 29, 2015
Immunological markers for prognostication in cytogenetically normal acute myeloid leukemia
Victoria Y Ling, Denise Lee, Zoe Mcquilten, et al.
World Journal of Surgery
|
September 27, 2022
How Effective is the Use of Molecular Testing in Preoperative Decision Making for Management of Indeterminate Thyroid Nodules?
David Steinmetz, Mary Kim, Jee-Hye Choi, et al.
Glia
|
November 20, 2025
Microglial VRK2 Regulates Astrocytic GABA Synthesis and Tonic Inhibition in the Thalamus
Dongsu Lee, Go Eun Ha, Yeleen Lee, et al.
American Journal of Surgery
|
March 16, 2026
A novel approach to parathyroidectomy for 4 gland disease: the NEAR project
Marine Coste, Isabelle Chu, Meghal M Shah, et al.
Blood Neoplasia
|
November 24, 2025
T-cell immune profile changes predict durable response to nivolumab-rituximab in treatment-naïve FL
Rachel M Koldej, Allison Barraclough, Huw Morgan, et al.
Blood Advances
|
January 24, 2025
Nivolumab and rituximab in treatment-naïve follicular lymphoma: the phase 2 1st FLOR study
Allison Barraclough, Sze Ting Lee, Melinda Burgess, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
January 25, 2024
Extent of Surgery for Medullary Thyroid Cancer and Prevalence of Occult Contralateral Foci
Yifan V Mao, Elena G Hughes, David Steinmetz, et al.
British Journal of Haematology
|
April 8, 2026
Checkpoint inhibitors, obinutuzumab plus PET-adapted ultra-low dose nodal radiotherapy yield high efficacy in treatment-naïve follicular lymphoma: Results from the phase II 'FLUORO' study
Arina Martynchyk, Geoffrey Chong, Richard Khor, et al.
Leukemia & Lymphoma
|
February 20, 2024
Australian experience with ibrutinib in patients with relapsed/refractory mantle cell lymphoma: a study from the Lymphoma and Related Diseases Registry
Diva Baggio, Cameron Wellard, Eliza Chung, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 39) with videos related to
Sort By:
Page
of 4
World Journal of Surgery
|
November 4, 2024
Safety of thyroidectomy as day care surgery at a rural setting in Eastern Uganda
Joseph Okello Damoi, Marnie Abeshouse, Angellica Giibwa, et al.
American Journal of Hematology
|
August 29, 2015
Immunological markers for prognostication in cytogenetically normal acute myeloid leukemia
Victoria Y Ling, Denise Lee, Zoe Mcquilten, et al.
World Journal of Surgery
|
September 27, 2022
How Effective is the Use of Molecular Testing in Preoperative Decision Making for Management of Indeterminate Thyroid Nodules?
David Steinmetz, Mary Kim, Jee-Hye Choi, et al.
Glia
|
November 20, 2025
Microglial VRK2 Regulates Astrocytic GABA Synthesis and Tonic Inhibition in the Thalamus
Dongsu Lee, Go Eun Ha, Yeleen Lee, et al.
American Journal of Surgery
|
March 16, 2026
A novel approach to parathyroidectomy for 4 gland disease: the NEAR project
Marine Coste, Isabelle Chu, Meghal M Shah, et al.
Blood Neoplasia
|
November 24, 2025
T-cell immune profile changes predict durable response to nivolumab-rituximab in treatment-naïve FL
Rachel M Koldej, Allison Barraclough, Huw Morgan, et al.
Blood Advances
|
January 24, 2025
Nivolumab and rituximab in treatment-naïve follicular lymphoma: the phase 2 1st FLOR study
Allison Barraclough, Sze Ting Lee, Melinda Burgess, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
January 25, 2024
Extent of Surgery for Medullary Thyroid Cancer and Prevalence of Occult Contralateral Foci
Yifan V Mao, Elena G Hughes, David Steinmetz, et al.
British Journal of Haematology
|
April 8, 2026
Checkpoint inhibitors, obinutuzumab plus PET-adapted ultra-low dose nodal radiotherapy yield high efficacy in treatment-naïve follicular lymphoma: Results from the phase II 'FLUORO' study
Arina Martynchyk, Geoffrey Chong, Richard Khor, et al.
Leukemia & Lymphoma
|
February 20, 2024
Australian experience with ibrutinib in patients with relapsed/refractory mantle cell lymphoma: a study from the Lymphoma and Related Diseases Registry
Diva Baggio, Cameron Wellard, Eliza Chung, et al.
Page
of 4